.png)
A patient with a complex diagnosis decides to seek a second opinion. They schedule an appointment with a specialist at a referral center, gather everything they have from the previous months, tests, reports, records, and arrive at the office expecting the new physician to start from where the care was and move forward. Most of the time, that is not what happens. The specialist receives a folder of documents from different laboratories and services, without enough time to reconcile them during the consultation, and frequently concludes that the safest path is to repeat the tests. The second opinion, which should build on what already exists, starts from scratch.
This restart is neither the physician's failure nor the patient's negligence. It is the direct consequence of a laboratory history that doesn't travel in a comparable way between points of care, and its cost is clinical, financial, and human at the same time.
What is lost in the transition between physicians
The moment a patient passes from one physician to another, whether for a second opinion, a referral to a specialist, or entry into a referral center, is one of the most fragile points in the chain of care. It is at this point that the accumulated clinical information needs to be transferred, and it is at this point that it is most frequently lost.
Kripalani and colleagues, in a reference study on communication between physicians in care transition, document that the transfer of information between the professional who was following the patient and the one who takes over is frequently incomplete, and that these communication deficits are associated with discontinuity and worse outcomes.¹ The laboratory history is one of the parts of this information that suffers most in the transition, precisely because it is voluminous, technical, and dispersed across multiple sources.
When this history arrives at the new physician as a collection of reports from different laboratories, with distinct nomenclatures, units, and reference ranges, it doesn't constitute a base on which the specialist can build with confidence. It constitutes a set of documents the specialist would have to decipher and reconcile before using, and the time to do that during a consultation simply doesn't exist. In the face of uncertainty, the most defensible clinical decision becomes repeating the tests, generating a new round of collections that, in a good share of cases, merely reproduces information the patient already brought.
The cost of unnecessary repetition
Repeating tests that have already been done, and whose results the patient already has, is a waste in several dimensions at the same time. From the system's standpoint, it is direct cost: each repeated test consumes supplies, staff time, and installed capacity that could have been used for another patient. From the patient's standpoint, it is time lost, new exposure to collections, and the postponement of the course of action the second opinion should have accelerated. From the clinical standpoint, it is the loss of longitudinal information: a test repeated today shows today's value, but doesn't recover the trajectory the previous tests contained and that the new physician couldn't read in a comparable way.
This last loss is the most serious and the least visible. The medicine of complex cases depends on the trajectory: how a biomarker evolved over time, how it responded to previous interventions, what pattern it described. When the new physician repeats the test instead of using the history, they recover an isolated point and lose the curve. The second opinion is deprived of precisely the information that would make it richer than the first, the temporal accumulation, and is reduced to a new evaluation from the present.
The literature on quality indicators in laboratory medicine recognizes that the unnecessary repetition of tests is a marker of system inefficiency, and that much of it results not from clinical necessity, but from the inability to access and use previous results.² The problem, again, is not the lack of tests. It is the inability to make usable the tests that already exist.
Why referral doesn't solve it alone
Referral and regulation systems organize the patient's flow between points of care, defining where they go and with what priority. But moving the patient is not the same as moving, in a usable way, the data that accompanies them. A referral can be perfectly executed from a logistical standpoint, the patient arrives at the right specialist at the right time, and still fail from an informational standpoint, because the laboratory history arrived along with it in a form the specialist can't use.
This is the difference between moving documents and moving usable clinical information. Referral resolves the patient's displacement and, at best, attaches their documents. What it doesn't resolve is the semantic comparability of those documents: the fact that tests from different sources need to be harmonized so the destination specialist can read them as a single, reliable trajectory. Without that harmonization, referral delivers the patient and the paperwork, but doesn't deliver the history.
Hallworth, in discussing the weight of clinical decisions that depend on laboratory results, reinforces that the value of the test is not in the act of performing it, but in its incorporation into the clinical decision.³ A test that was done, but whose result can't be used by the physician who needs to decide, is a test whose value was lost, even if the procedure was technically perfect. The repetition in the second opinion is the materialization of that loss: the value of the original test didn't reach the decision, and that is why the test had to be redone.
The history that arrives ready to be used
The alternative to starting from scratch is a laboratory history that arrives at the new physician already structured and comparable: with each test identified by a recognized standard, each unit normalized, each reference range documented, all organized into a timeline the specialist can read immediately. In this scenario, the second opinion starts from where the care was. The specialist sees the complete trajectory, evaluates the response to previous interventions, and decides whether any test actually needs to be redone, rather than repeating everything as a precaution in the face of data they couldn't interpret.
The effect of this change is distributed across the whole chain. The patient gains a second opinion that effectively uses their history, faster and less costly. The specialist gains a reliable base on which to exercise the clinical judgment the second opinion should offer. The system gains the savings of the avoided repetition. And care gains real continuity, the kind in which each new professional builds on the work of the previous one, rather than starting over.
This is where OpenHealth Technologies operates. The platform automatically correlates multiple data streams with rigorously validated logical layers of laboratory tests, transforming reports from different laboratories and services, in any format, into a structured and comparable history, mapped to LOINC, with normalized units and documented reference ranges, across over 3,500 biomarkers. For hospitals, clinics, and referral centers, this means the patient who arrives for a second opinion or a referral brings a laboratory trajectory the new physician can read immediately, and the second opinion stops starting from scratch to start from where the care was.